First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.42 USD 2.16% Market Closed
Updated: May 1, 2024

Wall Street
Price Targets

IDXG Price Targets Summary
Interpace Biosciences Inc

There are no price targets for IDXG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Interpace Biosciences Inc Competitors:
Price Targets
DVA
DaVita Inc
2% Downside
CHE
Chemed Corp
23% Upside
INFU
InfuSystem Holdings Inc
101% Upside
6639
Arrail Group Ltd
53% Upside
CCEL
Cryo-Cell International Inc
2% Downside
2273
Gushengtang Holdings Ltd
43% Upside
HIMS
Hims & Hers Health Inc
29% Upside
CARE
Dialogue Health Technologies Inc
4% Downside

Revenue
Forecast

Revenue Estimate
Interpace Biosciences Inc

For the last 8 years the compound annual growth rate for Interpace Biosciences Inc's revenue is 46%. The projected CAGR for the next 1 year is 41%.

46%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Interpace Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

Net Income Estimate
Interpace Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDXG's stock price target?
Not Available

IDXG doesn't have any price targets made by Wall Street professionals.

What is Interpace Biosciences Inc's Revenue forecast?
Projected CAGR
41%

For the last 8 years the compound annual growth rate for Interpace Biosciences Inc's revenue is 46%. The projected CAGR for the next 1 year is 41%.